Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Nivisa VakeesanDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.ORCID 0009-0006-6481-7425
Efren HerediaDepartment of Chemistry and Biochemistry, University of Nevada-Las Vegas, Las Vegas, NV 89154, USA.
Chandler HassanDepartment of Chemistry and Biochemistry, University of Nevada-Las Vegas, Las Vegas, NV 89154, USA.
Yang JiangDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.
Shiv SharmaDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.
Lianyong SuDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, VA 23298, USA.
Huiping ZhouDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, VA 23298, USA.ORCID 0000-0002-0050-372X
Steven FirestineDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.
Ernesto Abel-SantosDepartment of Chemistry and Biochemistry, University of Nevada-Las Vegas, Las Vegas, NV 89154, USA.ORCID 0000-0002-2628-9493
Wanqing LiuDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.ORCID 0000-0001-7727-6900
Funding
Using bile salt metabolism to modulate CDI prophylaxisR01AI109139 · NIAID · UNIVERSITY OF NEVADA LAS VEGAS · PI Ernesto V Abel-Santos · 2015 to 2026
$5.4M
PIGE: The Program Integrating Genomics and the EnvironmentT32ES036169 · NIEHS · WAYNE STATE UNIVERSITY · PI Wanqing Liu, Douglas M Ruden · 2025 to 2026
$560k
BLRD VA IK6 BX004477BLRD VA IK6BX004477BLRD VA IS1 BX004777NIAID NIH HHS R01 AI109139NIEHS NIH HHS T32 ES036169NIH HHS R01AI109139VA ShEEP 1IS1BX004777-01
6 · The paper itself
Abstract
We previously reported that two bile acid (BA) analogs, CamSA and CA-Quin, demonstrate potent anti-germination activity against
Indexed as
Bile Acids and SaltsClostridioides difficileClostridium InfectionsAnimalsFecesGastrointestinal MicrobiomeHomeostasisLiverMaleMiceRatsSpores, BacterialTranscriptomeBile Acids and Saltsbile acidC. difficileenterohepatic circulationgut microbiotatranscriptome
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Bile Acid Analogs with Anti-Germination Activities for Prophylaxis of · full record | OpenQuestion